Structural basis for C-ribosylation in the alnumycin A biosynthetic pathway

Alnumycin A is an exceptional aromatic polyketide that contains a carbohydrate-like 4′-hydroxy-5′-hydroxymethyl-2′,7′-dioxane moiety attached to the aglycone via a carbon−carbon bond. Recently, we have identified the D-ribose-5-phosphate origin of the dioxane unit and demonstrated that AlnA and AlnB are responsible for the overall C-ribosylation reaction. Here, we provide direct evidence that AlnA is a natural C-glycosynthase, which catalyzes the attachment of D-ribose-5-phosphate to prealnumycin by formation of the C8−C1′ bond as demonstrated by the structure of the intermediate alnumycin P. This compound is subsequently dephosphorylated by AlnB, an enzyme of the haloacid dehalogenase superfamily. Structure determination of the native trimeric AlnA to 2.1-Å resolution revealed a highly globular fold encompassing an α/β/α sandwich. The crystal structure of the complex with D-ribose-5-phosphate indicated that the phosphosugar is bound in the open-chain configuration. Identification of residues E29, K86, and K159 near the C-1 carbonyl of the ligand led us to propose that the carbon−carbon bond formation proceeds through a Michael-type addition. Determination of the crystal structure of the monomeric AlnB in the open conformation to 1.25-Å resolution showed that the protein consists of core and cap domains. Modeling of alnumycin P inside the cap domain positioned the phosphate group next to a Mg2+ ion present at the junction of the domains. Mutagenesis data were consistent with the canonical reaction mechanism for this enzyme family revealing the importance of residues D15 and D17 for catalysis. The characterization of the prealnumycin C-ribosylation illustrates an alternative means for attachment of carbohydrates to natural products.

[1]  M. Metsä-Ketelä,et al.  Biosynthetic pathway toward carbohydrate-like moieties of alnumycins contains unusual steps for C-C bond formation and cleavage , 2012, Proceedings of the National Academy of Sciences.

[2]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[3]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[4]  O. Leppäranta,et al.  Characterization of the alnumycin gene cluster reveals unusual gene products for pyran ring formation and dioxan biosynthesis. , 2008, Chemistry & biology.

[5]  R. Grayer,et al.  Flavonoids and their glycosides, including anthocyanins. , 2008, Natural product reports.

[6]  J. Collet,et al.  Molecular Identification of Pseudouridine-metabolizing Enzymes* , 2008, Journal of Biological Chemistry.

[7]  A. Bechthold,et al.  Glycosyltransferases, important tools for drug design. , 2008, Current topics in medicinal chemistry.

[8]  Fei Long,et al.  BALBES: a molecular-replacement pipeline , 2007, Acta crystallographica. Section D, Biological crystallography.

[9]  G. Schulz,et al.  Structure and action of the C-C bond-forming glycosyltransferase UrdGT2 involved in the biosynthesis of the antibiotic urdamycin. , 2007, Journal of molecular biology.

[10]  C. Thibodeaux,et al.  Unusual sugar biosynthesis and natural product glycodiversification , 2007, Nature.

[11]  S. Withers,et al.  Engineering of glycosidases and glycosyltransferases. , 2006, Current opinion in chemical biology.

[12]  Karen N. Allen,et al.  Evolutionary genomics of the HAD superfamily: understanding the structural adaptations and catalytic diversity in a superfamily of phosphoesterases and allied enzymes. , 2006, Journal of molecular biology.

[13]  G. Schneider,et al.  Crystal structure of the polyketide cyclase AknH with bound substrate and product analogue: implications for catalytic mechanism and product stereoselectivity. , 2006, Journal of molecular biology.

[14]  Tommi H. Nyrönen,et al.  SOMA - Workflow for Small Molecule Property Calculations on a Multiplatform Computing Grid , 2006, J. Chem. Inf. Model..

[15]  J. Thorson,et al.  Structure, activity, synthesis and biosynthesis of aryl-C-glycosides. , 2005, Natural product reports.

[16]  P. G. Hultin,et al.  Bioactive C-glycosides from bacterial secondary metabolism. , 2005, Current topics in medicinal chemistry.

[17]  Mitchell D. Miller,et al.  Crystal structure of an indigoidine synthase A (IndA)‐like protein (TM1464) from Thermotoga maritima at 1.90 Å resolution reveals a new fold , 2005, Proteins.

[18]  Karen N. Allen,et al.  Phosphoryl group transfer: evolution of a catalytic scaffold. , 2004, Trends in biochemical sciences.

[19]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[20]  A. Edwards,et al.  The 2.2 A resolution structure of RpiB/AlsB from Escherichia coli illustrates a new approach to the ribose-5-phosphate isomerase reaction. , 2003, Journal of molecular biology.

[21]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[22]  Henry H Nguyen,et al.  Structural characterization of the reaction pathway in phosphoserine phosphatase: crystallographic "snapshots" of intermediate states. , 2002, Journal of molecular biology.

[23]  M. Binaschi,et al.  Novel anthracycline oligosaccharides: influence of chemical modifications of the carbohydrate moiety on biological activity. , 2002, Bioorganic & medicinal chemistry.

[24]  F. Schluenzen,et al.  Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.

[25]  V. Křen,et al.  Glycosides in medicine: "The role of glycosidic residue in biological activity". , 2001, Current medicinal chemistry.

[26]  S. Kim,et al.  BeF(3)(-) acts as a phosphate analog in proteins phosphorylated on aspartate: structure of a BeF(3)(-) complex with phosphoserine phosphatase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Y. Watanabe,et al.  K1115 A, a new anthraquinone that inhibits the binding of activator protein-1 (AP-1) to its recognition sites. II. Taxonomy, fermentation, isolation, physico-chemical properties and structure determination. , 1998, The Journal of antibiotics.

[28]  J. Nüske,et al.  Alnumycin a new naphthoquinone antibiotic produced by an endophytic Streptomyces sp. , 1998, The Journal of antibiotics.

[29]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[30]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[31]  E. Toone,et al.  Specificity of C-glycoside complexation by mannose/glucose specific lectins. , 1996, Biochemistry.

[32]  C. Sander,et al.  Dali: a network tool for protein structure comparison. , 1995, Trends in biochemical sciences.

[33]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[34]  Serge X. Cohen,et al.  Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7 , 2008, Nature Protocols.

[35]  Andrew G. W. Leslie,et al.  Processing diffraction data with mosflm , 2007 .

[36]  Randy J. Read,et al.  Evolving Methods for Macromolecular Crystallography , 2007 .

[37]  A. Weymouth-Wilson The role of carbohydrates in biologically active natural products. , 1997, Natural product reports.

[38]  H. Pfander,et al.  Terpenoid glycosides. , 1991, Natural product reports.